The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" against pharmacy benefit managers.

NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.

CVS (CVS) and UnitedHealth Group (UNH) on Tuesday demanded that Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners recuse themselves from the agency’s lawsuit against the companies,

Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit

UnitedHealth Group, CVS Health and Cigna all submitted motions Oct. 8 to remove Lina Khan from the Federal Trade Commission’s ongoing antitrust lawsuit. | UnitedHealth, CVS Health and Cigna all view FTC chair Lina Khan as unfair toward PBMs and say she should be removed from the FTC's recently filed antitrust lawsuit.

UnitedHealth Group and CVS Health are asking FTC commissioners to recuse themselves from a case against pharmacy benefit managers due to alleged bias.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story PBMs seek removal of ‘biased’ FTC chair, commissionersThe three biggest pharmacy benefit

Attorneys argue Khan and two other commissioners are biased against pharmacy benefit managers and should recuse themselves from an ongoing lawsuit against the middlemen.

UnitedHealth and CVS Caremark are calling on a federal judge to disqualify Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners from the agency’s lawsuit against the country’s largest pharmacy benefit managers (PBMs).